http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GT-200100015-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C59-125
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C59-305
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-194
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G09F7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C43-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C59-125
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C51-41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C59-305
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-19
filingDate 2001-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d47136df8569e15ddccf7cbebedbb904
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_240d5f4bad3c5bfae87d73ddd145f7bc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b116fb2a08d91864253aa8cd60c4b197
publicationDate 2001-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GT-200100015-A
titleOfInvention ETERES OF CALCIUM DICARBOXYLATE, METHODS FOR THE PREPARATION AND TREATMENT OF VASCULAR DISEASES AND DIABETESCON THE SAME.
abstract THE PRESENT INVENTION REFERS TO THE MONOCALCIO SALT OF ACID 6 (5CARBOXI5METILHEXILOXI) 2,2, DIMELHEXANOICO (1: 1) AND ITS SOLVATOS, TO THE METHODS TO PRODUCE THE SALT IN CRYSTAL FORM, TO METHODS TO PRODUCE SOLVATOS DE LA SOLVATOS DE LA SOLVATOS SALT OF MONOCALCIO IN CRYSTAL FORM, AND THE TREATMENT OF DISEASES WITH THE SAME. IN PARTICULAR THE MENTIONED COMPOUNDS ARE USEFUL TO REDUCE CERTAIN PLASMATIC LIPIDS IN ANIMALS INCLUDING LP (A), TRIGLICERIDES, VLDLCOLESTEROL, AND LDLCOLESTEROL, AS WELL AS TO ELEVATE HDLCOLESTEROL. THE COMPOUNDS ARE USEFUL TO TREAT MELLITUS DIABETES.
priorityDate 2000-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460341
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559505

Total number of triples: 29.